ClinicalTrials.Veeva

Menu

Factors Associated With Failure of HFNO in COVID-19 ICU Patients (CO-OHD)

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

COVID-19 Pneumonia

Treatments

Device: high flow oxygen device

Study type

Observational

Funder types

Other

Identifiers

NCT05798234
2022PI120

Details and patient eligibility

About

To determine the factors associated with OHD failure in COVID-19 patients admitted to an Intensive Care Unit

Full description

Patients admitted into 1 participating ICU for acute hypoxemic respiratory failure due to COVID-19 between 02/01/2020 and 06/01/2022 will be assessed for OHD failure

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted in ICU for COVID-19 pneumonia

Exclusion criteria

  • under immediate ECMO
  • secondary transferred from another ICU
  • readmission in the ICU
  • initial limitation of care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems